Arixtra (fondaparinux sodium), the first in a new class of SYNTHETIC antithrombotics

Organon is now launching Arixtra (fondaparinux sodium), the first in a new class of SYNTHETIC antithrombotics.

It's even smaller than the low-molecular weight heparins.

This smaller size allows it to bind more selectively to factor Xa to inhibit thrombin formation.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote